SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-004382
Filing Date
2022-02-14
Accepted
2022-02-14 13:14:46
Documents
62
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 2485144
2 ex31-1.htm EX-31.1 14553
3 ex32-1.htm EX-32.1 5071
  Complete submission text file 0001493152-22-004382.txt   8867203

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ppcb-20211231.xsd EX-101.SCH 57520
5 XBRL CALCULATION FILE ppcb-20211231_cal.xml EX-101.CAL 55103
6 XBRL DEFINITION FILE ppcb-20211231_def.xml EX-101.DEF 257349
7 XBRL LABEL FILE ppcb-20211231_lab.xml EX-101.LAB 478015
8 XBRL PRESENTATION FILE ppcb-20211231_pre.xml EX-101.PRE 359178
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1370369
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 22628685
SIC: 2834 Pharmaceutical Preparations